Is OSCR stock a Buy, Sell, or Hold?

Based on our analysis, OSCR is currently a WAIT with low confidence. 📊 MIXED SIGNALS: OSCR shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of OSCR stock?

Our analysis estimates the fair value range for OSCR to be between $29.15 and $32.39. The current price is $32.77.

What is the analyst price target for OSCR?

The average Wall Street analyst price target for OSCR is $30.40. This implies a potential upside of -7.2% from current levels.

Oscar Health (OSCR) Stock: Buy, Sell, or Hold?

OSCR - Oscar Health, Inc.

HOSPITAL & MEDICAL SERVICE PLANS

$32.77

0.19 (0.58%) ▲

5d: +1.64%

30d: +10.67%

90d: +13.35%

WAIT

LOW Confidence

Protect Your OSCR Gains

Analysis Updated: Sep 11, 2026 12:00 AM ET

Earnings: Nov 05, 2026

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Sep 4, 2026 at $32.25 · last confirmed Sep 11, 2026

Strength: 8.2/10

Get Alerted When OSCR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: OSCR shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 7.5%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$36.82

Based on 5.8% avg growth

INTRINSIC VALUE TODAY

$22.86

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.8x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: OSCR is currently trading at $32.77, which is considered extended relative to its 30-day fair value range of $29.15 to $32.39. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.4) compared to its historical average (14.8). At these levels, the market is pricing in 5.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, OSCR is in a strong uptrend. Immediate support is located at $29.09, while resistance sits at $34.23.

Market Sentiment: OSCR scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $29.15 - $32.39

Company Quality Score 48/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 21.4%

Protect Your Profits

Holding OSCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
BEARISH: Weak technical setup (34/100)
BULLISH: High volume confirmation
BEARISH: Trading above Wall St target ($30.40)
NEUTRAL: PE elevated vs history but 5.5% growth expectation is conservative given 126% recent growth
WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $29.15 - $32.39

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $29.09

Resistance Level $34.23

Current Trend Strong Uptrend

Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 17.41

Wall Street Target $30.40 (-7.2%)

Revenue Growth (YoY) 70.4%

Earnings Growth (YoY) 125.6%

Profit Margin 3.6%

Valuation Premium vs History +5.5% premium

PE vs Historical 17.4 vs 14.8 STRETCHED

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +5.5% (market-implied from PE analysis)

1-Year Target $34.57 (+6%)

2-Year Target $36.47 (+11%)

3-Year Target $38.48 (+17%)

3-Yr Target (if PE normalizes) (PE: 17→15) PE COMPRESSION $32.71 (0%)

Earnings growth offset by PE compression

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.2, Growth: 7.5%) $47.16 (+44%)

Base: (SPY PE: 17.4, Growth: 7.5%) $40.71 (+24%)

Bear: (PE: 14.8, Growth: 7.5%) $34.60 (+6%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (17x PE) as earnings recover.

Trailing PE: 24.50 | Current EPS (TTM): $1.33

Bull Case $50.71 (+55%)

Analyst growth 41.5%, PE expands to 27.0

Base Case $46.10 (+41%)

Market implied 41.5%, PE stable at 24.5

Bear Case $22.15 (-32%)

Severe decline -20.0%, PE contracts to 20.8

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: September 14, 2026 1:41 AM ET
Data refreshes hourly during market hours. Next update: 2:41 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is OSCR showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS BUYING

Recent Transactions

Mark T Bertolini BUY 1000000 shares 2026-04-06

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for OSCR.

Create Free Account

Already have an account? Log In

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
CVS CVS Health Corp	STRONG BUY 28 analysts	$116	50 HOLD
UNH UnitedHealth Group Incor…	STRONG BUY 27 analysts	$475	49 HOLD
CI Cigna Corp	STRONG BUY 25 analysts	$339	51 HOLD
ELV Elevance Health Inc	STRONG BUY 22 analysts	$450	45 HOLD
HUM Humana Inc	HOLD 26 analysts	$419	49 HOLD

CVS CVS Health Corp

50 HOLD

UNH UnitedHealth Grou…

49 HOLD

CI Cigna Corp

51 HOLD

ELV Elevance Health I…

45 HOLD

HUM Humana Inc

49 HOLD

Advanced OSCR Option Strategies

Professional options setups generated by AI based on today's OSCR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for OSCR

OSCR Technical Chart OSCR Price Prediction OSCR Earnings Date OSCR Investment Advisor OSCR Fair Price Analyzer OSCR Options Advisor OSCR Options Chain OSCR Options Analysis OSCR Competitors

Compare OSCR with Peers

OSCR vs HIMS
Which one to buy?

OSCR vs ZETA
Which one to buy?

OSCR vs GRAB
Which one to buy?

OSCR vs TEM
Which one to buy?

OSCR vs ONDS
Which one to buy?

GRAB vs OSCR

OSCR vs CLOV
Winner: OSCR

Create New Comparison View All Competitors

Tradestie